Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Maintains Outperform on Wolfspeed, Lowers Price Target to $115

Oppenheimer analyst Colin Rusch maintains Wolfspeed (NYSE:WOLF) with a Outperform and lowers the price target from $118 to $115.
byBenzinga Newsdesk
January 26, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Colin Rusch maintains Wolfspeed (NYSE:WOLF) with a Outperform and lowers the price target from $118 to $115.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

WuXi Biologics Announces Research Service Agreement With BioNTech On Discovering Investigational Monoclonal Antibodies For Developing Next-Generation Therapeutic Product Candidates; WuXi Biologics Will Receive A $20M Upfront Payment

By Benzinga Newsdesk
January 10, 12:16 PM
WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its Research Service Unit (R in CRDMO) has signed a research service

BNTX